AgingResearch.NewsJoin free

Johnson & Johnson Surgical Vision

Part of Johnson & Johnson

CompanyUnited States

ROR

Johnson & Johnson Surgical Vision develops 2 assets, the furthest in phase 3 (TECNIS Odyssey IOL in dysphotopsia). Mostly device; based in the United States.

2
Assets
Furthest stage
Phase 3
0
Trials
1
Signal

Pipeline

2

  • TECNIS Odyssey IOL

    Full visual range diffractive continuous intraocular lens for correcting presbyopia

    Phase 3, Device, dysphotopsia, presbyopia

  • TECNIS PureSee IOL

    Pure refractive extended depth of focus intraocular lens for correcting presbyopia

    Phase 3, Device, dysphotopsia, presbyopia

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials2
  • Signals1
  • Similar companies3

Intelligence